Monday, July 29, 2019
Blood and Blood Product Safety and the Role of Government
One million Americans are infected with HIV. One in six of these people do not know that they are infected. In the 1980s, about 8,000 hemophiliacs were infected with HIV and hepatitis due to blood supply infections. Companies that sell drugs used to manage blood coagulation of the US Food and Drug Administration (FDA), Disease Control Center (CDC), Government, National Hemophilia Foundation (NHF), and hemophilia patients I know that the factor is contaminated. Either way, due to the high price of these products, they still sell it. The health of the United States depends on blood and technology. Blood and blood products play an important and irreplaceable role in medicine. Every year 5 million people receive erythrocytes, blood coagulation factors, or blood transfusions from plasma products. Traditionally, the technical aspects of blood have long been dedicated to improving blood safety, collection and storage. The system is not perfect, and some experts have expressed concern that r eaction to Jika is too slow and too cautious. Finding the right balance between speed and accuracy is always a problem and it is worth reviewing in future articles. However, from the viewpoint of winter of 2017, we can see that confirmed case of infection by transfusion has not been confirmed in the United States. In the past Prior to blood transfusion, many measures were taken to ensure the quality, compatibility and safety of blood products. In 2012, 70% of countries formulate domestic blood policies, 62% of which enact specific laws covering transfusion safety and quality. Blood transfusions usually use blood sources: themselves (autologous blood transfusion) or other people (allogeneic or allogeneic transfusions). The latter is more general than the former. To use other people's blood, you need to donate blood first. Blood is most often injected intravenously into whole blood and collected with anticoagulants. In developed countries, donors are usually anonymous to recipients, b ut products in blood banks can always be individually tracked through donation, testing, separation of ingredients, storage, and delivery to recipients throughout the cycle .